METHOD FOR DEVELOPING BIOMARKERS OF DISEASES AND PHYSIOLOGICALLY ACTIVE SUBSTANCES BASED ON EXTENDED VERSION OF THE IPANDA ALGORITHM Russian patent published in 2019 - IPC G01N33/48 C12Q1/68 G06F3/06 G06F12/02 

Abstract RU 2703534 C1

FIELD: medicine.

SUBSTANCE: proposed group of inventions relates to medicine. Method and a system for evaluating the efficacy of drug candidates selected from a group of drug candidates for a physiological process are disclosed. Method involves obtaining data from samples in which said physiological process takes place, and from control samples in which said physiological process does not occur, determining a set of genes or their products and signalling pathways statistically significantly activated or inhibited in samples in which said physiological process, as compared to control samples, determining a set of genes and signalling pathways after exposure of each drug candidate selected from a group of drug candidates to cells or biological tissues in which said physiological process can occur, and determining efficacy values for said physiological process for each drug candidate.

EFFECT: proposed group of inventions provides a more effective method of assessing the effectiveness of drug candidates for a physiological process.

3 cl, 7 dwg, 3 tbl, 3 ex

Similar patents RU2703534C1

Title Year Author Number
ONCOBOX GENETIC INFORMATION ANALYSIS PLATFORM 2018
  • Buzdin Anton Aleksandrovich
  • Sorokin Maksim Igorevich
  • Tkachev Viktor Sergeevich
  • Nikitin Daniil Mikhailovich
  • Zolotovskaia Marianna Arsenovna
  • Garazha Andrei Vladimirovich
  • Borisov Nikolai Mikhailovich
RU2741703C1
METHOD OF SEARCHING FOR THERAPEUTICALLY SIGNIFICANT MOLECULAR TARGETS FOR DISEASES BY APPLYING MACHINE LEARNING METHODS TO COMBINED DATA INCLUDING SIGNALING PATHWAY GRAPHS, OMIX AND TEXT DATA TYPES 2022
  • Naumov Vladimir Aleksandrovich
  • Kozlova Ekaterina Sergeevna
  • Ozerov Ivan Vitalevich
  • Aliper Aleksandr Mironovich
  • Zhavoronkov Aleksandr
RU2798897C1
METHOD FOR SEARCHING TARGET PROTEINS TRIGGERING PROCESS OF CARCINOGENESIS, IN INDIVIDUAL PATIENT'S TISSUE SAMPLES FOR PURPOSES OF SUBSEQUENT ANTITUMOUR MEDICINAL TREATMENT 2013
  • Kotelnikova Ekaterina Aleksandrovna
  • Pjatnitskij Mikhail Alekseevich
RU2577107C2
METHOD OF CREATING TARGET PANEL FOR STUDYING GENOMIC REGIONS FOR DETECTING THERAPEUTIC BIOMARKERS OF IMMUNE CHECKPOINT (IC) INHIBITORS 2023
  • Yudin Sergej Mikhajlovich
  • Keskinov Anton Arturovich
  • Makarov Valentin Vladimirovich
  • Yudin Vladimir Sergeevich
  • Makarova Anna Sergeevna
  • Kotyurgin Aleksandr Pavlovich
  • Bugaev-Makarovskij Nikolaj Andreevich
  • Ershov Pavel Viktorovich
  • Snigir Ekaterina Andreevna
  • Makhotenko Antonida Viktorovna
  • Maralova Ekaterina Dmitrievna
  • Vanyushina Yuliya Nikolaevna
  • Kikot Aleksandra Denisovna
RU2818360C1
SELECTION OF CANCER PATIENTS FOR INTRODUCTION OF WNT SIGNAL INHIBITORS BASED ON RNF43 MUTATION STATUS 2013
  • Tsun Fen
  • Khao Khuajsyan
  • Khsiekh Khsin-I
  • Tszyan Syaomo
  • Lyu Tszyun
  • Ng Nikolas
RU2636000C2
SYSTEM FOR SIMULATING MOLECULAR INTERACTIONS INVOLVED IN THE INFLAMMATORY PROCESS 2020
  • Gupta Shajlendra Kumar
  • Chesnulevichyus Konstantin
RU2804998C2
BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS 2013
  • Bais, Karlos
  • Brauer, Mettyu
  • Shmidt, Majke
  • Singkh, Mallika
RU2659173C2
BIOMARKERS FOR THERAPY, BASED ON HEDGEHOG INHIBITOR 2012
  • Bandaru Radzh
  • Khajder Asifa
  • Robinson Duglas Majkl
  • Rouz Kristin Linn
  • Sharp Ted Tajson
  • Shou Japin
RU2602185C2
METHOD OF USING AXL AS MARKER OF EPITHELIAL-MESENCHYMAL TRANSITION 2010
  • Lorens Dzhejms Bredli
  • Miklem Devid Robert
  • Akslen Lars
RU2586493C2
MICRORNA-124 AS BIOMARKER 2014
  • Tazi Zhamal
  • Sherrer Dide
  • Garsel Od
  • Kampos Noeli
  • Nazhman Romen
  • Mayuto-Betzer Florens
RU2687366C2

RU 2 703 534 C1

Authors

Ozerov Ivan Vitalevich

Aliper Aleksandr Mironovich

Zhavoronkov Aleksandr

Dates

2019-10-21Published

2018-06-09Filed